Why the study?
To explore risk factors for carotid atherosclerosis in rural Northwest China and assess whether reducing serum homocysteine prevents carotid atherosclerosis in hyperhomocysteinemia.
Does reducing serum homocysteine prevent carotid atherosclerosis in subjects with hyperhomocysteinemia?
Does reducing serum homocysteine prevent carotid atherosclerosis in subjects with hyperhomocysteinemia?
Age, hypertension, and LDL-C predict carotid atherosclerosis progression; Hcy reduction leaves open its preventive role in hyperhomocysteinemia.
Objective: To explore the risk factors for carotid atherosclerosis in the rural areas of Northwest China, and to assess whether reducing serum homocysteine can prevent carotid atherosclerosis in subjects with hyperhomocysteinemia. Method: This observational study with 767 participants aged 40 years or older was conducted over 3 years. Color Doppler ultrasonography was performed to measure carotid atherosclerosis. We recorded biochemical indexes and carotid ultrasound results in the first and fourth years. Result: A total of 767 individuals (48.5 % men) were analyzed. Older age, hypertension, and higher levels of baseline low-density lipoprotein cholesterol (LDL-C) were risk factors for increased carotid intima-media thickness (CIMT), carotid plaque, and carotid stenosis (All P < 0.05). No association was found between decreased serum homocysteine (Hcy) levels and CIMT, carotid plaque, or carotid stenosis in individuals with hyperhomocysteinemia. Conclusion: Older age, hypertension, and higher baseline levels of LDL-C were independent risk factors for carotid atherosclerosis. Reducing serum Hcy levels may not prevent carotid atherosclerosis in the general population with hyperhomocysteinemia.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: